TGF-beta RI/ALK-5 Antibody (854621R) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3025E
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 854621R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TGF-beta RI/ALK-5
Leu34-Glu125
Accession # P36897
Leu34-Glu125
Accession # P36897
Specificity
Detects human TGF-beta RI/ALK-5 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TGF-beta RI/ALK-5 Antibody (854621R) [DyLight 405]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TGF-beta RI/ALK-5
Long Name
Transforming Growth Factor beta Receptor I
Alternate Names
ALK-5, SKR4, TGF-bRI, TGFbetaRI, TGFBR1
Additional TGF-beta RI/ALK-5 Products
Product Documents for TGF-beta RI/ALK-5 Antibody (854621R) [DyLight 405]
Product Specific Notices for TGF-beta RI/ALK-5 Antibody (854621R) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...